Lakefront Biotherapeutics | GLPG - Заемный капитал





Заемный капитал Изменить Дата
argenx SE USD 35.57M 3.05M 2025-06
AstraZeneca USD 25.96B 177M 2026-03
Biogen USD 6.29B 1.7M 2026-03
Genmab DKK 5.14B 5.01B 2025-12
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 14.01B 696M 2026-03
GRIFOLS EUR 9.08B 612M 2026-03
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Incyte USD 29.41M 785K 2026-03
Merck EUR 10.8B 72M 2026-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 37.45B 7.86B 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03
UCB EUR 2.18B 634M 2025-12
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12